Rivermark Medical

Medical was founded by a practicing urologist with the aim of developing the preferred first-line device therapy for benign prostatic hyperplasia. The FloStent System enables physicians to treat patients safely and effectively, minimizing discomfort and reducing complications. The FloStent System is designed for rapid restoration of normal urinary function, preservation of sexual function, and improvement in patients' overall quality of life. The FloStent System is the first product that Rivermark Medical plans to bring to market.